Pfizer to expand COVID drug production in France

Montag, 17. Januar 2022 11:08

Pfizer Inc. CEO Albert Bourla announced on Monday that the company will invest €520 million in France over the course of five years. The pharma giant will cooperate with French company Novasep on the production of COVID-19 treatments and research.

Bourla also commented on the pandemic in an interview with Figaro, stating that "this wave will be the last one with this many restrictions." He warned the virus will continue to circulate, but expressed hope that "we will return to a more normal life."

Relevante Links: Pfizer Inc.
Baha Breaking News (BBN) / DJ